STOCK TITAN

10x Genomics to Present at the Cowen 42nd Annual Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

10x Genomics (Nasdaq: TXG) will participate in the Cowen 42nd Annual Health Care Conference on March 7, 2022, at 12:50 p.m. ET. The company's management will engage in a virtual fireside chat to discuss business activities. Interested parties can access the live and archived webcast through the company's website.

Recognized for advancing human health, 10x Genomics provides integrated solutions for biological analysis, widely used by premier research institutions and pharmaceutical companies globally.

Positive
  • None.
Negative
  • None.

PLEASANTON, Calif., March 1, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the company will be participating in the upcoming Cowen 42nd Annual Health Care Conference.

10x Genomics' management is scheduled to virtually participate in a fireside chat on Monday, March 7, at 12:50 p.m. Eastern Time/9:50 a.m. Pacific Time to discuss its business activities.  Interested parties may access a live and archived webcast of the presentation on the "Investors" section of the company's website at: https://investors.10xgenomics.com/.

About 10x Genomics

10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company's integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2020 based on publications and all of the top 20 global pharmaceutical companies by 2020 research and development spend and have been cited in over 3,300 research papers on discoveries ranging from oncology to immunology and neuroscience. The company's patent portfolio comprises more than 1,300 issued patents and patent applications.

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Media Contact:
media@10xgenomics.com

Investor Relations Contact:
investors@10xgenomics.com

Cision View original content:https://www.prnewswire.com/news-releases/10x-genomics-to-present-at-the-cowen-42nd-annual-health-care-conference-301493257.html

SOURCE 10x Genomics, Inc.

FAQ

What is the date of the 10x Genomics participation in the Cowen 42nd Annual Health Care Conference?

10x Genomics will participate in the Cowen 42nd Annual Health Care Conference on March 7, 2022.

What time will 10x Genomics' fireside chat take place?

The fireside chat will occur at 12:50 p.m. Eastern Time / 9:50 a.m. Pacific Time.

Where can I access the webcast for 10x Genomics' conference presentation?

The webcast can be accessed on the Investors section of 10x Genomics' website.

What does 10x Genomics focus on in the life sciences sector?

10x Genomics focuses on mastering biology to advance human health through their integrated solutions for analyzing biological systems.

How many patents does 10x Genomics hold?

10x Genomics holds over 1,300 issued patents and patent applications.

10x Genomics, Inc.

NASDAQ:TXG

TXG Rankings

TXG Latest News

TXG Stock Data

1.69B
103.99M
2.15%
96.03%
5.67%
Health Information Services
Laboratory Analytical Instruments
Link
United States of America
PLEASANTON